177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Name: 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.
Published: 2015
License: Public Domain

University Hospital, Basel, Switzerland · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

thyroid cancer, medullary, neuroendocrine tumor of the lung grade 1 and 2, neuroendocrine tumor of the thymus grade 1 and 2, neuroendocrine tumor gep grade 1-3, calcitonin, medullary thyroid carcinoma, peptide receptor radionuclide therapy, gastrin, cholecystokinin-2 receptor, neuroendocrine tumor, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Related documents